Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study
Background: Atrial fibrillation (AF) and obesity are common conditions globally; yet, there remains suboptimal pharmacological management contributing to high rates of hospitalization in patients with AF. The altered pathophysiology of both obese and underweight individuals may influence the pharmac...
Saved in:
Main Authors: | Fahad Shaikh (Author), Rochelle Wynne (Author), Ronald L. Castelino (Author), Sally C. Inglis (Author), Patricia M. Davidson (Author), Caleb Ferguson (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
by: Z. D. Kobalava, et al.
Published: (2021) -
Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation
by: Caroline Brais, et al.
Published: (2017) -
Gastrointestinal protection options for direct oral anticoagulants in patients with atrial fibrillation
by: Natalya M. Vorobyeva, et al.
Published: (2022) -
Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation
by: S. V. Malchikova, et al.
Published: (2020) -
Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
by: Soo Min Jang, et al.
Published: (2020)